Category:Pages with missing NCBI ID
From BugSigDB
When resolving issues shown on this page, please read and make notes on the Discussion page to avoid duplicating work. See https://en.wikipedia.org/wiki/Open_nomenclature for help with nomenclature conventions, and use the NCBI Taxonomy Browser. Also here is a 2-hour video of Levi Waldron working on mapping issues on this page to the NCBI taxonomy.
Pages in category "Pages with missing NCBI ID"
The following 200 pages are in this category, out of 692 total.
(previous page) (next page)S
- Intestinal microbiota in patients with chronic hepatitis C with and without cirrhosis compared with healthy controls/Experiment 1/Signature 2
- Impacts of Dietary Protein and Niacin Deficiency on Reproduction Performance, Body Growth, and Gut Microbiota of Female Hamsters (Tscherskia triton) and Their Offspring/Experiment 1/Signature 1
- Impacts of Dietary Protein and Niacin Deficiency on Reproduction Performance, Body Growth, and Gut Microbiota of Female Hamsters (Tscherskia triton) and Their Offspring/Experiment 3/Signature 1
- The gut microbiota is associated with psychiatric symptom severity and treatment outcome among individuals with serious mental illness/Experiment 1/Signature 2
- The gut microbiota is associated with psychiatric symptom severity and treatment outcome among individuals with serious mental illness/Experiment 3/Signature 2
- The gut microbiota is associated with psychiatric symptom severity and treatment outcome among individuals with serious mental illness/Experiment 5/Signature 1
- The gut microbiota is associated with psychiatric symptom severity and treatment outcome among individuals with serious mental illness/Experiment 6/Signature 1
- Gut microbial-derived butyrate is inversely associated with IgE responses to allergens in childhood asthma/Experiment 1/Signature 2
- Shifts in Lachnospira and Clostridium sp. in the 3-month stool microbiome are associated with preschool age asthma/Experiment 2/Signature 2
- Differences in the gut microbiome by physical activity and BMI among colorectal cancer patients/Experiment 6/Signature 2
- Gut microbiota imbalance and its correlations with hormone and inflammatory factors in patients with stage 3/4 endometriosis/Experiment 1/Signature 2
- Gut Microbiome Changes Associated With HIV Infection and Sexual Orientation/Experiment 1/Signature 2
- Gut Microbiome Changes Associated With HIV Infection and Sexual Orientation/Experiment 2/Signature 2
- Duodenal and rectal mucosal microbiota related to small intestinal bacterial overgrowth in diarrhea-predominant irritable bowel syndrome/Experiment 3/Signature 1
- Ketogenic Diets Alter the Gut Microbiome Resulting in Decreased Intestinal Th17 Cells/Experiment 2/Signature 1
- Ketogenic Diets Alter the Gut Microbiome Resulting in Decreased Intestinal Th17 Cells/Experiment 2/Signature 2
- Ketogenic Diets Alter the Gut Microbiome Resulting in Decreased Intestinal Th17 Cells/Experiment 3/Signature 2
- Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression/Experiment 1/Signature 1
- Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression/Experiment 1/Signature 2
- Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression/Experiment 2/Signature 1
- Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression/Experiment 3/Signature 1
- Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression/Experiment 3/Signature 2
- Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression/Experiment 5/Signature 1
- Evolution of the Gut Microbiome in HIV-Exposed Uninfected and Unexposed Infants during the First Year of Life/Experiment 8/Signature 1
- Gut microbiome signatures reflect different subtypes of irritable bowel syndrome/Experiment 1/Signature 1
- Gut microbiome signatures reflect different subtypes of irritable bowel syndrome/Experiment 1/Signature 2
- Gut microbiome signatures reflect different subtypes of irritable bowel syndrome/Experiment 2/Signature 1
- A Comparison of Tumor-Associated and Non-Tumor-Associated Gastric Microbiota in Gastric Cancer Patients/Experiment 2/Signature 2
- The small bowel microbiome changes significantly with age and aspects of the ageing process/Experiment 1/Signature 2
- Sputum Microbiome and Chronic Obstructive Pulmonary Disease in a Rural Ugandan Cohort of Well-Controlled HIV Infection/Experiment 1/Signature 1
- Sputum Microbiome and Chronic Obstructive Pulmonary Disease in a Rural Ugandan Cohort of Well-Controlled HIV Infection/Experiment 2/Signature 1
- Sputum Microbiome and Chronic Obstructive Pulmonary Disease in a Rural Ugandan Cohort of Well-Controlled HIV Infection/Experiment 2/Signature 2
- Microbiome diversity in African American, European American, and Egyptian colorectal cancer patients/Experiment 4/Signature 1
- Microbiome diversity in African American, European American, and Egyptian colorectal cancer patients/Experiment 5/Signature 1
- Gut Microbial Signatures Can Discriminate Unipolar from Bipolar Depression/Experiment 2/Signature 1
- Dysbiosis and Implication of the Gut Microbiota in Diabetic Retinopathy/Experiment 2/Signature 2
- Dysbiosis and Implication of the Gut Microbiota in Diabetic Retinopathy/Experiment 3/Signature 1
- Gastrointestinal tract involvement in systemic sclerosis: The roles of diet and the microbiome/Experiment 2/Signature 2
- Gastrointestinal tract involvement in systemic sclerosis: The roles of diet and the microbiome/Experiment 3/Signature 2
- Gastrointestinal tract involvement in systemic sclerosis: The roles of diet and the microbiome/Experiment 4/Signature 2
- Changes in gut microbiota composition and diversity associated with post-cholecystectomy diarrhea/Experiment 1/Signature 1
- Changes in gut microbiota composition and diversity associated with post-cholecystectomy diarrhea/Experiment 2/Signature 1
- Antibiotic treatment using amoxicillin-clavulanic acid impairs gut mycobiota development through modification of the bacterial ecosystem/Experiment 2/Signature 2
- COVID-19 mRNA vaccine-mediated antibodies in human breast milk and their association with breast milk microbiota composition/Experiment 4/Signature 1
- COVID-19 mRNA vaccine-mediated antibodies in human breast milk and their association with breast milk microbiota composition/Experiment 5/Signature 2
- COVID-19 mRNA vaccine-mediated antibodies in human breast milk and their association with breast milk microbiota composition/Experiment 6/Signature 1
- COVID-19 mRNA vaccine-mediated antibodies in human breast milk and their association with breast milk microbiota composition/Experiment 6/Signature 2
- Association Between Breastmilk Microbiota and Food Allergy in Infants/Experiment 1/Signature 2
- Sex-specific differences in intestinal microbiota associated with cardiovascular diseases/Experiment 1/Signature 1
- Sex-specific differences in intestinal microbiota associated with cardiovascular diseases/Experiment 1/Signature 2
- Sex-specific differences in intestinal microbiota associated with cardiovascular diseases/Experiment 2/Signature 2
- Sex-specific differences in intestinal microbiota associated with cardiovascular diseases/Experiment 3/Signature 1
- Sex-specific differences in intestinal microbiota associated with cardiovascular diseases/Experiment 3/Signature 2
- Sex-specific differences in intestinal microbiota associated with cardiovascular diseases/Experiment 4/Signature 1
- Sex-specific differences in intestinal microbiota associated with cardiovascular diseases/Experiment 4/Signature 2
- Changes and significance of gut microbiota in children with focal epilepsy before and after treatment/Experiment 1/Signature 3
- Changes and significance of gut microbiota in children with focal epilepsy before and after treatment/Experiment 3/Signature 2
- Yearly variation coupled with social interactions shape the skin microbiome in free-ranging rhesus macaques/Experiment 1/Signature 1
- Comparison of changes in fecal microbiota of calves with and without dam/Experiment 2/Signature 2
- Comparison of changes in fecal microbiota of calves with and without dam/Experiment 3/Signature 2
- Trans-ethnic gut microbiota signatures of type 2 diabetes in Denmark and India/Experiment 3/Signature 1
- Trans-ethnic gut microbiota signatures of type 2 diabetes in Denmark and India/Experiment 3/Signature 2
- Trans-ethnic gut microbiota signatures of type 2 diabetes in Denmark and India/Experiment 5/Signature 1
- Smoking and salivary microbiota: a cross-sectional analysis of an Italian alpine population/Experiment 1/Signature 2
- Tear film microbiome in Sjogren's and non-Sjogren's aqueous deficiency dry eye/Experiment 1/Signature 1
- Tear film microbiome in Sjogren's and non-Sjogren's aqueous deficiency dry eye/Experiment 1/Signature 2
- Tear film microbiome in Sjogren's and non-Sjogren's aqueous deficiency dry eye/Experiment 2/Signature 1
- Tear film microbiome in Sjogren's and non-Sjogren's aqueous deficiency dry eye/Experiment 3/Signature 2
- Metagenomics Analysis to Investigate the Microbial Communities and Their Functional Profile During Cyanobacterial Blooms in Lake Varese/Experiment 1/Signature 1
- Feeding Rapidly Alters Microbiome Composition and Gene Transcription in the Clownfish Gut/Experiment 1/Signature 1
- Feeding Rapidly Alters Microbiome Composition and Gene Transcription in the Clownfish Gut/Experiment 2/Signature 1
- Feeding Rapidly Alters Microbiome Composition and Gene Transcription in the Clownfish Gut/Experiment 3/Signature 1
- Feeding Rapidly Alters Microbiome Composition and Gene Transcription in the Clownfish Gut/Experiment 4/Signature 2
- Gut microbiome predicts gastrointestinal toxicity outcomes from chemoradiation therapy in patients with head and neck squamous cell carcinoma/Experiment 1/Signature 1
- Gut microbiome predicts gastrointestinal toxicity outcomes from chemoradiation therapy in patients with head and neck squamous cell carcinoma/Experiment 1/Signature 2
- Gut microbiome predicts gastrointestinal toxicity outcomes from chemoradiation therapy in patients with head and neck squamous cell carcinoma/Experiment 2/Signature 1
- Gut microbiome predicts gastrointestinal toxicity outcomes from chemoradiation therapy in patients with head and neck squamous cell carcinoma/Experiment 2/Signature 2
- Gut microbiome predicts gastrointestinal toxicity outcomes from chemoradiation therapy in patients with head and neck squamous cell carcinoma/Experiment 3/Signature 1
- Gut microbiome predicts gastrointestinal toxicity outcomes from chemoradiation therapy in patients with head and neck squamous cell carcinoma/Experiment 3/Signature 2
- Establishment of a non-Westernized gut microbiota in men who have sex with men is associated with sexual practices/Experiment 1/Signature 2
- Establishment of a non-Westernized gut microbiota in men who have sex with men is associated with sexual practices/Experiment 9/Signature 1
- Establishment of a non-Westernized gut microbiota in men who have sex with men is associated with sexual practices/Experiment 10/Signature 1
- Establishment of a non-Westernized gut microbiota in men who have sex with men is associated with sexual practices/Experiment 10/Signature 2
- Establishment of a non-Westernized gut microbiota in men who have sex with men is associated with sexual practices/Experiment 11/Signature 2
- Establishment of a non-Westernized gut microbiota in men who have sex with men is associated with sexual practices/Experiment 12/Signature 1
- Establishment of a non-Westernized gut microbiota in men who have sex with men is associated with sexual practices/Experiment 13/Signature 2
- Establishment of a non-Westernized gut microbiota in men who have sex with men is associated with sexual practices/Experiment 14/Signature 1
- Vaginal Microbiome in Pregnant Women with and without Short Cervix/Experiment 1/Signature 1
- Oral microbiome and preterm birth/Experiment 1/Signature 1
- Oral microbiome and preterm birth/Experiment 1/Signature 2
- PandaGUT provides new insights into bacterial diversity, function, and resistome landscapes with implications for conservation/Experiment 1/Signature 1
- Differential Microbial Signature Associated With Benign Prostatic Hyperplasia and Prostate Cancer/Experiment 1/Signature 2
- Alterations in the Gut Microbiota and Metabolomics of Seafarers after a Six-Month Sea Voyage/Experiment 1/Signature 1
- Alterations in the Gut Microbiota and Metabolomics of Seafarers after a Six-Month Sea Voyage/Experiment 1/Signature 2
- Effects of proton pump inhibitor on the human gut microbiome profile in multi-ethnic groups in Singapore/Experiment 3/Signature 1
- Profiling the Urinary Microbiota in Male Patients With Bladder Cancer in China/Experiment 1/Signature 2
- Profiling the Urinary Microbiota in Male Patients With Bladder Cancer in China/Experiment 2/Signature 1
- Profiling the Urinary Microbiota in Male Patients With Bladder Cancer in China/Experiment 3/Signature 1
- Alterations in the Gut Microbiome of Young Children with Airway Allergic Disease Revealed by Next-Generation Sequencing/Experiment 1/Signature 1
- Characterization of microbial communities in the chicken oviduct and the origin of chicken embryo gut microbiota/Experiment 1/Signature 2
- Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson's Disease/Experiment 1/Signature 1
- Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson's Disease/Experiment 1/Signature 2
- Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson's Disease/Experiment 2/Signature 1
- Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson's Disease/Experiment 2/Signature 2
- The long-term gut bacterial signature of a wild primate is associated with a timing effect of pre- and postnatal maternal glucocorticoid levels/Experiment 1/Signature 1
- The long-term gut bacterial signature of a wild primate is associated with a timing effect of pre- and postnatal maternal glucocorticoid levels/Experiment 1/Signature 2
- The long-term gut bacterial signature of a wild primate is associated with a timing effect of pre- and postnatal maternal glucocorticoid levels/Experiment 2/Signature 1
- The long-term gut bacterial signature of a wild primate is associated with a timing effect of pre- and postnatal maternal glucocorticoid levels/Experiment 2/Signature 2
- The long-term gut bacterial signature of a wild primate is associated with a timing effect of pre- and postnatal maternal glucocorticoid levels/Experiment 3/Signature 1
- The long-term gut bacterial signature of a wild primate is associated with a timing effect of pre- and postnatal maternal glucocorticoid levels/Experiment 3/Signature 2
- The long-term gut bacterial signature of a wild primate is associated with a timing effect of pre- and postnatal maternal glucocorticoid levels/Experiment 4/Signature 1
- The long-term gut bacterial signature of a wild primate is associated with a timing effect of pre- and postnatal maternal glucocorticoid levels/Experiment 4/Signature 2
- The long-term gut bacterial signature of a wild primate is associated with a timing effect of pre- and postnatal maternal glucocorticoid levels/Experiment 5/Signature 1
- The long-term gut bacterial signature of a wild primate is associated with a timing effect of pre- and postnatal maternal glucocorticoid levels/Experiment 5/Signature 2
- The long-term gut bacterial signature of a wild primate is associated with a timing effect of pre- and postnatal maternal glucocorticoid levels/Experiment 6/Signature 1
- The long-term gut bacterial signature of a wild primate is associated with a timing effect of pre- and postnatal maternal glucocorticoid levels/Experiment 6/Signature 2
- The long-term gut bacterial signature of a wild primate is associated with a timing effect of pre- and postnatal maternal glucocorticoid levels/Experiment 7/Signature 1
- The long-term gut bacterial signature of a wild primate is associated with a timing effect of pre- and postnatal maternal glucocorticoid levels/Experiment 7/Signature 2
- The long-term gut bacterial signature of a wild primate is associated with a timing effect of pre- and postnatal maternal glucocorticoid levels/Experiment 8/Signature 1
- The long-term gut bacterial signature of a wild primate is associated with a timing effect of pre- and postnatal maternal glucocorticoid levels/Experiment 8/Signature 2
- Comprehensive profiles and diagnostic value of menopausal-specific gut microbiota in premenopausal breast cancer/Experiment 1/Signature 2
- Comprehensive profiles and diagnostic value of menopausal-specific gut microbiota in premenopausal breast cancer/Experiment 2/Signature 2
- Differential effects of antiretroviral treatment on immunity and gut microbiome composition in people living with HIV in rural versus urban Zimbabwe/Experiment 4/Signature 2
- Parkinson's Disease Medication Alters Small Intestinal Motility and Microbiota Composition in Healthy Rats/Experiment 1/Signature 2
- Parkinson's Disease Medication Alters Small Intestinal Motility and Microbiota Composition in Healthy Rats/Experiment 2/Signature 2
- Parkinson's Disease Medication Alters Small Intestinal Motility and Microbiota Composition in Healthy Rats/Experiment 3/Signature 1
- Parkinson's Disease Medication Alters Small Intestinal Motility and Microbiota Composition in Healthy Rats/Experiment 4/Signature 2
- Parkinson's Disease Medication Alters Small Intestinal Motility and Microbiota Composition in Healthy Rats/Experiment 5/Signature 1
- Parkinson's Disease Medication Alters Small Intestinal Motility and Microbiota Composition in Healthy Rats/Experiment 5/Signature 2
- Parkinson's Disease Medication Alters Small Intestinal Motility and Microbiota Composition in Healthy Rats/Experiment 6/Signature 2
- A metagenomic study of the gut microbiome in Behcet's disease/Experiment 2/Signature 1
- A metagenomic study of the gut microbiome in Behcet's disease/Experiment 3/Signature 1
- Intestinal microbiome and metabolome signatures in patients with chronic granulomatous disease/Experiment 4/Signature 2
- Intestinal microbiome and metabolome signatures in patients with chronic granulomatous disease/Experiment 5/Signature 2
- Differential Analysis of Gut Microbiota Correlated With Oxidative Stress in Sows With High or Low Litter Performance During Lactation/Experiment 1/Signature 1
- Differential Analysis of Gut Microbiota Correlated With Oxidative Stress in Sows With High or Low Litter Performance During Lactation/Experiment 2/Signature 2
- Differential Analysis of Gut Microbiota Correlated With Oxidative Stress in Sows With High or Low Litter Performance During Lactation/Experiment 3/Signature 1
- Differential Analysis of Gut Microbiota Correlated With Oxidative Stress in Sows With High or Low Litter Performance During Lactation/Experiment 3/Signature 2
- Differential Analysis of Gut Microbiota Correlated With Oxidative Stress in Sows With High or Low Litter Performance During Lactation/Experiment 4/Signature 1
- Longitudinal and Comparative Analysis of Gut Microbiota of Tunisian Newborns According to Delivery Mode/Experiment 7/Signature 1
- Gut microbiota are related to Parkinson's disease and clinical phenotype/Experiment 1/Signature 1
- Association of the Cervical Microbiota With Pregnancy Outcome in a Subfertile Population Undergoing In Vitro Fertilization: A Case-Control Study/Experiment 1/Signature 2
- Specific gastrointestinal microbiota profiles in Chinese Tan sheep are associated with lauric acid content in muscle/Experiment 4/Signature 1
- Specific gastrointestinal microbiota profiles in Chinese Tan sheep are associated with lauric acid content in muscle/Experiment 7/Signature 2
- Oral Fungal Alterations in Patients with COVID-19 and Recovered Patients/Experiment 1/Signature 1
- Oral Fungal Alterations in Patients with COVID-19 and Recovered Patients/Experiment 2/Signature 1
- Oral Fungal Alterations in Patients with COVID-19 and Recovered Patients/Experiment 3/Signature 1
- Oral Fungal Alterations in Patients with COVID-19 and Recovered Patients/Experiment 4/Signature 2
- Oral Fungal Alterations in Patients with COVID-19 and Recovered Patients/Experiment 6/Signature 1
- Oral Fungal Alterations in Patients with COVID-19 and Recovered Patients/Experiment 9/Signature 2
- Oral Fungal Alterations in Patients with COVID-19 and Recovered Patients/Experiment 10/Signature 1
- Immunoregulatory role of the gut microbiota in inflammatory depression/Experiment 1/Signature 1
- Immunoregulatory role of the gut microbiota in inflammatory depression/Experiment 1/Signature 2
- Immunoregulatory role of the gut microbiota in inflammatory depression/Experiment 3/Signature 1
- Immunoregulatory role of the gut microbiota in inflammatory depression/Experiment 4/Signature 1
- Immunoregulatory role of the gut microbiota in inflammatory depression/Experiment 6/Signature 1
- Immunoregulatory role of the gut microbiota in inflammatory depression/Experiment 7/Signature 1
- Modified Mediterranean-ketogenic diet modulates gut microbiome and short-chain fatty acids in association with Alzheimer's disease markers in subjects with mild cognitive impairment/Experiment 1/Signature 1
- Progression of Parkinson's disease is associated with gut dysbiosis: Two-year follow-up study/Experiment 2/Signature 1
- Progression of Parkinson's disease is associated with gut dysbiosis: Two-year follow-up study/Experiment 3/Signature 1
- Progression of Parkinson's disease is associated with gut dysbiosis: Two-year follow-up study/Experiment 4/Signature 1
- Guts within guts: the microbiome of the intestinal helminth parasite Ascaris suum is derived but distinct from its host/Experiment 8/Signature 2
- Guts within guts: the microbiome of the intestinal helminth parasite Ascaris suum is derived but distinct from its host/Experiment 9/Signature 1
- Guts within guts: the microbiome of the intestinal helminth parasite Ascaris suum is derived but distinct from its host/Experiment 9/Signature 2
- Identification of Gut Microbiome and Metabolites Associated with Acute Diarrhea in Cats/Experiment 1/Signature 2
- Identification of Gut Microbiome and Metabolites Associated with Acute Diarrhea in Cats/Experiment 2/Signature 2
- Identification of Gut Microbiome and Metabolites Associated with Acute Diarrhea in Cats/Experiment 4/Signature 2
- Identification of Gut Microbiome and Metabolites Associated with Acute Diarrhea in Cats/Experiment 5/Signature 2
- Identification of Gut Microbiome and Metabolites Associated with Acute Diarrhea in Cats/Experiment 6/Signature 1
- A Pilot Study Exploring the Association of Entacapone, Gut Microbiota, and the Subsequent Side Effects in Patients With Parkinson's Disease/Experiment 1/Signature 1
- The alteration of intestinal mucosal α-synuclein expression and mucosal microbiota in Parkinson's disease/Experiment 1/Signature 2
- The alteration of intestinal mucosal α-synuclein expression and mucosal microbiota in Parkinson's disease/Experiment 2/Signature 2
- 16S rRNA gene sequencing reveals altered gut microbiota in young adults with schizophrenia and prominent negative symptoms/Experiment 1/Signature 2
- 16S rRNA gene sequencing reveals altered gut microbiota in young adults with schizophrenia and prominent negative symptoms/Experiment 2/Signature 1
- Oral and gut dysbiosis leads to functional alterations in Parkinson's disease/Experiment 1/Signature 2
- Oral and gut dysbiosis leads to functional alterations in Parkinson's disease/Experiment 2/Signature 1
- Oral and gut dysbiosis leads to functional alterations in Parkinson's disease/Experiment 3/Signature 1
- Oral and gut dysbiosis leads to functional alterations in Parkinson's disease/Experiment 3/Signature 2
- Oral and gut dysbiosis leads to functional alterations in Parkinson's disease/Experiment 4/Signature 1
- Oral and gut dysbiosis leads to functional alterations in Parkinson's disease/Experiment 4/Signature 2
- Oral and gut dysbiosis leads to functional alterations in Parkinson's disease/Experiment 5/Signature 1
- Oral and gut dysbiosis leads to functional alterations in Parkinson's disease/Experiment 5/Signature 2
- Analysis on the change of gut microbiota and metabolome in lung transplant patients/Experiment 1/Signature 2
- Analysis on the change of gut microbiota and metabolome in lung transplant patients/Experiment 2/Signature 2
- Pronounced gut microbiota signatures in patients with JAK2V617F-positive essential thrombocythemia/Experiment 3/Signature 1
- Pronounced gut microbiota signatures in patients with JAK2V617F-positive essential thrombocythemia/Experiment 4/Signature 2
- Curcumin Regulates Gut Microbiota and Exerts a Neuroprotective Effect in the MPTP Model of Parkinson's Disease/Experiment 1/Signature 1
- Curcumin Regulates Gut Microbiota and Exerts a Neuroprotective Effect in the MPTP Model of Parkinson's Disease/Experiment 1/Signature 2
- Curcumin Regulates Gut Microbiota and Exerts a Neuroprotective Effect in the MPTP Model of Parkinson's Disease/Experiment 2/Signature 1
- Curcumin Regulates Gut Microbiota and Exerts a Neuroprotective Effect in the MPTP Model of Parkinson's Disease/Experiment 2/Signature 2
- Curcumin Regulates Gut Microbiota and Exerts a Neuroprotective Effect in the MPTP Model of Parkinson's Disease/Experiment 3/Signature 1
- Curcumin Regulates Gut Microbiota and Exerts a Neuroprotective Effect in the MPTP Model of Parkinson's Disease/Experiment 3/Signature 2
- Effects of removing in-feed antibiotics and zinc oxide on the taxonomy and functionality of the microbiota in post weaning pigs/Experiment 7/Signature 2
- Intestinal microbiota influences clinical outcome and side effects of early breast cancer treatment/Experiment 8/Signature 1
- The Gut Microbiome in Parkinson's Disease: A Longitudinal Study of the Impacts on Disease Progression and the Use of Device-Assisted Therapies/Experiment 1/Signature 1
- The Gut Microbiome in Parkinson's Disease: A Longitudinal Study of the Impacts on Disease Progression and the Use of Device-Assisted Therapies/Experiment 5/Signature 1
- Dysbiosis of gut microbiota inhibits NMNAT2 to promote neurobehavioral deficits and oxidative stress response in the 6-OHDA-lesioned rat model of Parkinson's disease/Experiment 1/Signature 2
- Study of gut microbiota alterations in Alzheimer's dementia patients from Kazakhstan/Experiment 1/Signature 1
- Study of gut microbiota alterations in Alzheimer's dementia patients from Kazakhstan/Experiment 1/Signature 2
- Study of gut microbiota alterations in Alzheimer's dementia patients from Kazakhstan/Experiment 2/Signature 1
